Cite
HARVARD Citation
O'Neil, P. et al. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 392 (10148), pp. 637-649. [Online].